Today Medtronic announces what is sure to be the first of a whole new generation of diabetes management software: its CareLink® Pro 3.0 Therapy Management Software — the first system to include algorithms capable of analyzing data from a patient’s insulin pump, continuous glucose monitoring (CGM) de
The FDA has approved Medtronic’s CareLink Pro 3.0 Therapy Management Software, a software program that offers decision support to healthcare professionals managing diabetes. The company announced a market launch in the U.S.
“With the new CareLink Pro reports that aggregate data into one place, I will now be able to assess my patients’ glucose control and insulin delivery within minutes. In addition, by using the new therapy considerations, I will be able to spend much less time on data interpretation and more time using this information to discuss diabetes management with my patients,” said Jill Abelseth, M.D., FACE of The Endocrine Group.






Smart Diabetes Software






| © 2012
{ 0 comments… add one now }
{ 2 trackbacks }